Welcome to the official website of ReNew Biotechnology Limited!
Company introduction

The ReNew Biotechnology Limited developed “Biomimicking Photocrosslinkable Nanocomposite (BPN) bone grafts”, which mirror the structure of natural bone and are fabricated under simple and green, low-temperature and organic solvent-free conditions. The bone grafts can load and long-term release bioactive molecules, activate cell signalling pathways to simultaneously promote osteogenesis and angiogenesis, while providing optimal mechanical support to the injured area, expediting the bone-healing process.

 

Utilizing its unique properties, our BPN can be used as (1) 3D printed bone scaffolds of varying dimensions, (2) micropatterned artificial periostea for coupled osteogenesis and angiogenesis and (3) subaqueous-crosslinking injectable osteochondral adhesives.

The technology has generated several patents and has been published by prestigious journals Advanced Functional Materials twice ((IF 19.924), 2021, 2104636 & 2023, 2213428), Biomaterials ((IF 15.304), 2020, 8, 120378) and Advanced Healthcare Materials ((IF 11.092), 2022, 2201220, journal cover). It has also won the Silver Medal at the Special Edition 2021 Inventions Geneva and 2023 TechConnect Global Innovation Award. Moreover, it has been reported by various media such as HK Ta Kung Pao and HK 01.

 

We believe our BPN products can compete in the growing market and serve a huge number of patients who are receiving orthopaedic surgeries. Over the long term, we believe our technologies could improve modern health service standards and people’s quality of life, ultimately benefitting millions of patients locally and globally.